位置:首页 > 蛋白库 > VE1_HPV33
VE1_HPV33
ID   VE1_HPV33               Reviewed;         644 AA.
AC   P06421;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1988, sequence version 1.
DT   03-AUG-2022, entry version 99.
DE   RecName: Full=Replication protein E1 {ECO:0000255|HAMAP-Rule:MF_04000};
DE            EC=3.6.4.12 {ECO:0000255|HAMAP-Rule:MF_04000};
DE   AltName: Full=ATP-dependent helicase E1 {ECO:0000255|HAMAP-Rule:MF_04000};
GN   Name=E1 {ECO:0000255|HAMAP-Rule:MF_04000};
OS   Human papillomavirus 33.
OC   Viruses; Monodnaviria; Shotokuvirae; Cossaviricota; Papovaviricetes;
OC   Zurhausenvirales; Papillomaviridae; Firstpapillomavirinae;
OC   Alphapapillomavirus.
OX   NCBI_TaxID=10586;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3009902; DOI=10.1128/jvi.58.3.991-995.1986;
RA   Cole S.T., Streeck R.E.;
RT   "Genome organization and nucleotide sequence of human papillomavirus type
RT   33, which is associated with cervical cancer.";
RL   J. Virol. 58:991-995(1986).
RN   [2]
RP   DOMAIN E2 PROTEIN BINDING.
RX   PubMed=8623535; DOI=10.1006/viro.1996.0242;
RA   Mueller F., Sapp M.;
RT   "Domains of the E1 protein of human papillomavirus type 33 involved in
RT   binding to the E2 protein.";
RL   Virology 219:247-256(1996).
CC   -!- FUNCTION: ATP-dependent DNA helicase required for initiation of viral
CC       DNA replication. It forms a complex with the viral E2 protein. The E1-
CC       E2 complex binds to the replication origin which contains binding sites
CC       for both proteins. During the initial step, a dimer of E1 interacts
CC       with a dimer of protein E2 leading to a complex that binds the viral
CC       origin of replication with high specificity. Then, a second dimer of E1
CC       displaces the E2 dimer in an ATP-dependent manner to form the E1
CC       tetramer. Following this, two E1 monomers are added to each half of the
CC       site, which results in the formation of two E1 trimers on the viral
CC       ori. Subsequently, two hexamers will be created. The double hexamer
CC       acts as a bi-directional helicase machinery and unwinds the viral DNA
CC       and then recruits the host DNA polymerase to start replication.
CC       {ECO:0000255|HAMAP-Rule:MF_04000}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.12;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_04000};
CC   -!- SUBUNIT: Can form hexamers. Interacts with E2 protein; this interaction
CC       increases E1 DNA binding specificity. Interacts with host DNA
CC       polymerase subunit POLA2. Interacts with host single stranded DNA-
CC       binding protein RPA1. Interacts with host TOP1; this interaction
CC       stimulates the enzymatic activity of TOP1. {ECO:0000255|HAMAP-
CC       Rule:MF_04000}.
CC   -!- SUBCELLULAR LOCATION: Host nucleus {ECO:0000255|HAMAP-Rule:MF_04000}.
CC   -!- PTM: Phosphorylated. {ECO:0000255|HAMAP-Rule:MF_04000}.
CC   -!- PTM: Sumoylated. {ECO:0000255|HAMAP-Rule:MF_04000}.
CC   -!- SIMILARITY: Belongs to the papillomaviridae E1 protein family.
CC       {ECO:0000255|HAMAP-Rule:MF_04000}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M12732; AAA46960.1; -; Genomic_DNA.
DR   PIR; A03660; W1WL33.
DR   SMR; P06421; -.
DR   Proteomes; UP000009118; Genome.
DR   GO; GO:0042025; C:host cell nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:RHEA.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003678; F:DNA helicase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-UniRule.
DR   Gene3D; 1.10.10.510; -; 1.
DR   Gene3D; 3.40.50.300; -; 1.
DR   HAMAP; MF_04000; PPV_E1; 1.
DR   InterPro; IPR001177; DNA_helicase_E1_C_Papillomavir.
DR   InterPro; IPR014000; DNA_helicase_E1_N_Papillomavir.
DR   InterPro; IPR014015; Helicase_SF3_DNA-vir.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR016393; Rep_E1_papillomaV.
DR   InterPro; IPR037102; Znf_lg_T-Ag_D1_dom_sf.
DR   Pfam; PF00519; PPV_E1_C; 1.
DR   Pfam; PF00524; PPV_E1_N; 1.
DR   PIRSF; PIRSF003383; Rep_E1_papillomaV; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51206; SF3_HELICASE_1; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; DNA replication; DNA-binding; Early protein; Helicase;
KW   Host nucleus; Hydrolase; Isopeptide bond; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   CHAIN           1..644
FT                   /note="Replication protein E1"
FT                   /id="PRO_0000133131"
FT   DOMAIN          444..594
FT                   /note="SF3 helicase"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04000"
FT   REGION          179..345
FT                   /note="DNA-binding region"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04000"
FT   REGION          312..644
FT                   /note="Required for E2 binding"
FT   MOTIF           86..88
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04000"
FT   BINDING         470..477
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04000"
FT   CROSSLNK        551
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04000"
SQ   SEQUENCE   644 AA;  72469 MW;  F6F5A93C9E32D201 CRC64;
     MADPEGTNGA GMGCTGWFEV EAVIERRTGD NISEDEDETA DDSGTDLLEF IDDSMENSIQ
     ADTEAARALF NIQEGEDDLN AVCALKRKFA ACSQSAAEDV VDRAANPCRT SINKNKECTY
     RKRKIDELED SGYGNTEVET QQMVQQVESQ NGDTNLNDLE SSGVGDDSEV SCETNVDSCE
     NVTLQEISNV LHSSNTKANI LYKFKEAYGI SFMELVRPFK SDKTSCTDWC ITGYGISPSV
     AESLKVLIKQ HSLYTHLQCL TCDRGIIILL LIRFRCSKNR LTVAKLMSNL LSIPETCMVI
     EPPKLRSQTC ALYWFRTAMS NISDVQGTTP EWIDRLTVLQ HSFNDNIFDL SEMVQWAYDN
     ELTDDSDIAY YYAQLADSNS NAAAFLKSNS QAKIVKDCGI MCRHYKKAEK RKMSIGQWIQ
     SRCEKTNDGG NWRPIVQLLR YQNIEFTAFL GAFKKFLKGI PKKSCMLICG PANTGKSYFG
     MSLIQFLKGC VISCVNSKSH FWLQPLSDAK IGMIDDVTPI SWTYIDDYMR NALDGNEISI
     DVKHRALVQL KCPPLLLTSN TNAGTDSRWP YLHSRLTVFE FKNPFPFDEN GNPVYAINDE
     NWKSFFSRTW CKLDLIEEED KENHGGNIST FKCSAGENTR SLRS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024